Condition
Gastrointestinal Stromal Tumor (GIST) clinical trials and research
Research outlook What's coming for Gastrointestinal stromal tumor: the next 6 months to 5 yearsAs of November 12, 2026, Find a Trial lists 9 Gastrointestinal Stromal Tumor (GIST) clinical trials that are recruiting, at sites in 4 countries (most in United States (5), China (2), Italy (1)). By phase: Phase 1 (2), Phase 1/2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 9Clinical trials
- 4Countries
Newest Gastrointestinal Stromal Tumor (GIST) clinical trials
All recruiting trials (9)
-
GIST Patient Registry for real-world insights
This registry collects medical information from people with GIST to see how the disease behaves in real life and to help improve care.
-
ctDNA-guided precision care for lung, GIST, colorectal, biliary, and ovarian cancers
This trial tests a blood test that looks for tumor DNA in patients with several cancers to help guide personalized treatment decisions.
-
AI using endoscopic ultrasound and white-light endoscopy to diagnose upper GI mesenchymal tumors
This project will test a multimodal AI tool that uses endoscopic ultrasound, white-light endoscopy images, and clinical data to help diagnose and risk-stratify upper gastrointestinal subepithelial tumors in adults who have had endoscopy.
-
International registry for very rare childhood tumors
This project will collect detailed medical information to see how clinical and biological features affect outcomes in children and adolescents with very rare tumors.
-
Combining ziftomenib and imatinib for advanced gastrointestinal stromal tumors
This study is testing whether combining two medications, ziftomenib and imatinib, can help adults with advanced gastrointestinal stromal tumors who haven't responded well to imatinib alone.
-
Evaluating DCC-3009 for treating gastrointestinal stromal tumors
This study is testing a new treatment called DCC-3009 for people with gastrointestinal stromal tumors to see if it is safe and effective, either on its own or with other cancer therapies.
-
Collecting tumor tissue from patients with gastrointestinal stromal tumors for research
This study is collecting tumor samples from people with gastrointestinal stromal tumors to help researchers learn more about the disease and how to treat it better.
-
Testing HQP1351 for GIST and other solid tumors
This study is testing a new drug called HQP1351 to see if it can help people with gastrointestinal stromal tumors and other solid tumors feel better and how much of the drug is safe to use.
-
Research on upper gastrointestinal cancers using tissue and blood samples
This study is trying to learn more about gastric and esophageal cancers by looking at tissue and blood samples from patients to find out how genes and proteins affect these diseases.
Related topics
Quick answers
How many Gastrointestinal Stromal Tumor (GIST) clinical trials are recruiting right now?
9, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 4 countries. The most sites are in United States (5 trials), China (2 trials), Italy (1 trial), United Kingdom (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 2, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.